PA
MDT icon

Parallel Advisors’s Medtronic MDT Stock Holding History

Parallel Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.15M Buy
24,856
+663
+3% +$63.5K 0.04% 281
2025
Q4 		$2.32M Buy
24,193
+2,497
+12% +$243K 0.04% 263
2025
Q3 		$2.07M Buy
21,696
+989
+5% +$90.9K 0.04% 278
2025
Q2 		$1.81M Sell
20,707
-2,722
-12% -$231K 0.04% 294
2025
Q1 		$2.11M Buy
23,429
+3,593
+18% +$322K 0.05% 246
2024
Q4 		$1.58M Buy
19,836
+1,407
+8% +$122K 0.04% 284
2024
Q3 		$1.66M Sell
18,429
-1,190
-6% -$100K 0.04% 279
2024
Q2 		$1.54M Sell
19,619
-1,344
-6% -$110K 0.04% 272
2024
Q1 		$1.83M Buy
20,963
+1,572
+8% +$134K 0.05% 250
2023
Q4 		$1.6M Sell
19,391
-1,209
-6% -$92.1K 0.05% 249
2023
Q3 		$1.61M Buy
20,600
+404
+2% +$33.8K 0.05% 222
2023
Q2 		$1.78M Sell
20,196
-1,164
-5% -$100K 0.06% 220
2023
Q1 		$1.72M Buy
21,360
+5,845
+38% +$476K 0.06% 223
2022
Q4 		$1.21M Sell
15,515
-2,694
-15% -$218K 0.05% 228
2022
Q3 		$1.47M Buy
18,209
+4,095
+29% +$368K 0.07% 185
2022
Q2 		$1.27M Sell
14,114
-3,652
-21% -$370K 0.06% 204
2022
Q1 		$1.98M Buy
17,766
+6,098
+52% +$644K 0.08% 167
2021
Q4 		$1.21M Sell
11,668
-3,076
-21% -$356K 0.04% 244
2021
Q3 		$1.85M Buy
14,744
+1,501
+11% +$194K 0.07% 173
2021
Q2 		$1.64M Buy
13,243
+1,701
+15% +$214K 0.07% 187
2021
Q1 		$1.36M Buy
11,542
+788
+7% +$92.4K 0.06% 193
2020
Q4 		$1.26M Buy
10,754
+582
+6% +$64.1K 0.07% 186
2020
Q3 		$1.06M Buy
10,172
+1,645
+19% +$165K 0.07% 183
2020
Q2 		$781K Sell
8,527
-345
-4% -$33.1K 0.05% 217
2020
Q1 		$800K Sell
8,872
-358
-4% -$38.1K 0.06% 176
2019
Q4 		$1.05M Buy
9,230
+331
+4% +$36.3K 0.08% 178
2019
Q3 		$967K Buy
8,899
+868
+11% +$90.6K 0.08% 175
2019
Q2 		$782K Sell
8,031
-212
-3% -$19.4K 0.08% 179
2019
Q1 		$750K Buy
8,243
+241
+3% +$21.6K 0.08% 172
2018
Q4 		$727K Buy
8,002
+906
+13% +$84.7K 0.1% 148
2018
Q3 		$698K Buy
7,096
+385
+6% +$35.6K 0.09% 167
2018
Q2 		$574K Buy
6,711
+2,127
+46% +$178K 0.08% 165
2018
Q1 		$368K Sell
4,584
-170
-4% -$14K 0.06% 217
2017
Q4 		$384K Buy
4,754
+375
+9% +$30K 0.06% 202
2017
Q3 		$347K Buy
4,379
+258
+6% +$21.4K 0.06% 224
2017
Q2 		$346K Buy
4,121
+247
+6% +$20.8K 0.07% 223
2017
Q1 		$326K Buy
3,874
+687
+22% +$53.7K 0.06% 211
2016
Q4 		$227K Buy
+3,187
New +$250K 0.05% 236

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parallel Advisors's MDT Position: Q1 2026 in Review

Parallel Advisors increased its Medtronic (MDT) stake by 2.7% in Q1 2026, buying an estimated $63.5K and bringing the position to 24,856 shares worth $2.15M. The position accounts for 0.04% of the portfolio, ranked #281.

Parallel Advisors first reported a position in MDT in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.32M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Parallel Advisors held 24,856 shares of Medtronic worth $2.15M as of Q1 2026.
  • Parallel Advisors bought 663 Medtronic shares in Q1 2026, an estimated $63.5K.
  • Medtronic made up 0.04% of Parallel Advisors's portfolio in Q1 2026, its #281 holding.
  • Parallel Advisors first reported a position in Medtronic in Q4 2016 and has held it in 38 quarters since.
  • Parallel Advisors's Medtronic position peaked at $2.32M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.